Target intelligence / Profile preview

P2X Purinoceptor (P2XR)

Target
P2XR
Molecular classification
Ligand-gated ion channel, Receptor
01

Overview

P2X purinoceptors are a family of ligand-gated ion channels activated by extracellular adenosine 5′-triphosphate (ATP). They are nonselective cation channels, permeable to sodium (Na⁺), potassium (K⁺), and calcium (Ca²⁺) ions. These receptors mediate fast excitatory synaptic transmission and play key roles in various physiological processes, including neurotransmission, inflammation, pain perception, immune responses, and cell death. There are seven recognized P2X receptor subunits: P2X1 through P2X7. Functional receptors can be homomeric or heteromeric assemblies of these subunits. Each receptor is a trimer composed of three subunits arranged around a central pore. ATP binding induces conformational changes that open the channel within milliseconds, allowing cation influx into cells. P2X purinoceptors have diverse functions depending on tissue localization, including roles in the nervous system, immune system, smooth muscle, and platelets. Several antagonists have been developed targeting specific receptor subtypes, and P2XR antagonists are being explored clinically for conditions including chronic coughs, neuropathic pain syndromes, and neurodegenerative diseases.

Other names
ATP-gated P2X receptorP2X receptor
02

Mechanism of action

Antagonism or allosteric modulation of P2X receptor subtypes, leading to altered ion channel activity and downstream signaling.

03

Biological functions

Synaptic transmissionImmune responseInflammation modulationPain modulationSmooth muscle contractionPlatelet aggregationCell death
04

Disease associations

Neuropathic painNeurodegenerative diseaseMultiple sclerosisInflammationCancerCardiovascular diseaseChronic cough
05

Safety considerations

Potential for off-target effects due to structural similarity between subtypes.Development of resistance.Immune related adverse eventsCardiovascular issues due to vasodilation side effects
06

Interacting drugs

NF279

6 more in the full profile.

Beyond the preview

Go deeper on P2X Purinoceptor (P2XR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on P2X Purinoceptor (P2XR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call